BiotechTube
Home/Catapult Therapeutics/Cecilia Muñoz (Muñoz-Calleja)
CM

Cecilia Muñoz (Muñoz-Calleja)

Scientific Founder

Catapult Therapeutics

Therapeutic Areas

OncologyHematology

Catapult Therapeutics Pipeline

DrugIndicationPhase
CAP-100Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Phase 1

Leadership Team at Catapult Therapeutics

DH
Dominik Höchli
Co-Managing Director
View full Catapult Therapeutics profile